Stay updated on Efficacy of LDX in Adolescent ADHD: Clinical Trial
Sign up to get notified when there's something new on the Efficacy of LDX in Adolescent ADHD: Clinical Trial page.

Latest updates to the Efficacy of LDX in Adolescent ADHD: Clinical Trial page
- CheckyesterdayChange DetectedThe record now presents details of a completed Phase 3 study comparing lisdexamfetamine with placebo in adolescents with ADHD, including eligibility criteria, study sites, and outcome measures.SummaryDifference64%

- Check8 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA banner announces NIH’s transition-related updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe study page now displays a 403 Forbidden error, preventing viewing of the study details.SummaryDifference17%

Stay in the know with updates to Efficacy of LDX in Adolescent ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of LDX in Adolescent ADHD: Clinical Trial page.